Sanofi Seeks Initial Offers for Its $20 Billion Consumer Arm

  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 38 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 35%
  • Publisher: 63%

Bloomberg News

Sanofi,Consumer Health Division,PAI Partners

(Bloomberg) -- Sanofi SA has called for initial bids for its $20 billion consumer health division, as the French pharmaceutical giant simultaneously moves...

-- Sanofi SA has called for initial bids for its $20 billion consumer health division, as the French pharmaceutical giant simultaneously moves forward with preparations for a possible listing of the business, according to people familiar with the matter.Julian Assange Leaves Court ‘Free Man,’ Ending 14-Year Drama

Sanofi is likely to retain a significant minority stake in the business after any sale, which would reduce the amount of capital that bidders need to commit, the people said. Representatives for the buyout firms declined to comment. Spokespeople for Deutsche Bank and Barclays didn’t immediately respond to requests for comment, while the other banks declined to comment.

KKR and TPG are among suitors which have expressed initial interest in $11 billion Italian drugmaker Recordati SpA, Bloomberg News reported in June, while EQT is considering a potential sale of Karo Healthcare in a deal that could value the Swedish consumer-health business at more than €2 billion .The Lahaina fire worsened Maui's housing shortage.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 47. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Sanofi Seeks Initial Offers for Its $20 Billion Consumer ArmSanofi SA has called for initial bids for its $20 billion consumer health division, as the French pharmaceutical giant simultaneously moves forward with preparations for a possible listing of the business, according to people familiar with the matter.
Source: BNNBloomberg - 🏆 83. / 50 Read more »